Light chain disease or myeloma with Bence Jones paraprotein
Yelin, C.A.; Rojman, J.A.
Prensa Medica Argentina 59(15): 572-574
1972
ISSN/ISBN: 0032-745X PMID: 5050453 Document Number: 57295
Document emailed within 1 workday
Related Documents
G.Mead, P.; H.D. Carr-Smith; M.Drayson, T.; A.R. Bradwell 2003: Detection of Bence Jones Myeloma and Monitoring of Myeloma Chemotherapy UsingImmunoassays Specific for Free Immunoglobulin Light Chains Clinical Laboratory 49(1-2): 25-27Togawa, A.; Imamura, Y. 1980: Study on the Bence Jones protein--molecular weight and polymeric forms of Bence Jones proteins Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 43(5): 850-855
Rebollar, J.L.; Villegas, A.; Martinez, E.; Gilsanz, V. 1976: Bence-Jones' myeloma Revista Clinica Espanola 143(1): 45-51
Trizio, D.; Ferrannini, A. 1970: Chromosome studies in a case of Bence Jones myeloma Haematologica 55(12): 774-777
Sanchez de cos Escuin, J.; Moreno Norueira, J.; Carneado de la Fuente, J. 1978: Bence-Jones myeloma. Clinical aspects, analysis and evolution Revista Clinica Espanola 150(6): 345-349
Caenazzo, A.; Sartori, D.; Poletti, A. 1997: Bence Jones myeloma with signet-ring-like plasma cells Haematologica 82(1): 122
Woodruff, R.; Sweet, B. 1977: Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function Australian and New Zealand Journal of Medicine 7(1): 60-62
Skvaril, F. 1981: Bence Jones protein and immunoglobulin light chains (immunochemical determination) La Ricerca in Clinica e in Laboratorio 11(Suppl 2): 55-63
Buxbaum, J.N.; Chuba, J.V.; Hellman, G.C.; Solomon, A.; Gallo, G.R. 1990: Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis Annals of Internal Medicine 112(6): 455-464
McLaughlin, C.L.; Solomon, A. 1971: Bence Jones proteins and light chains of immunoglobulins. VI. Immunochemical detection of interclass similarities among kappa-chains Journal of Immunology 107(6): 1699-1705
Pascali, E.; Pezzoli, A.; Romeo, G.; Feruglio, F.S. 1990: Bence-Jones proteinuria in multiple sclerosis: a possible indicator of disease activity Recenti Progressi in Medicina 81(12): 797-800
Leinonen, P.; Somer, T. 1988: Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins Duodecim; Laaketieteellinen Aikakauskirja 104(18): 1466-1470
Munárriz, B.; Molins, C.; Ballester, M.; Ramos, V. 1994: Cardiac amyloidosis and light chain myeloma Revista Clinica Espanola 194(9): 730
Taylor, D.G. 1974: Bence Jones proteinuria Journal of the Tennessee Medical Association 67(5): 409
Redón, J.; Caballero, M.; Herranz, C. 1982: Light chain myeloma: clinical study and prognostic factors Medicina Clinica 79(2): 54-58
El Naggar, A.A.; El-Naggar, M.; Mokhamer, E.-H.; Avad, M.W. 2015: Prognostic Value of Serum Free Light Chain in Multiple Myeloma Egyptian Journal of Immunology 22(1): 69-78
Perry, M.C.; Kyle, R.A. 1975: The clinical significance of Bence Jones proteinuria Mayo Clinic Proceedings 50(5): 234-238
Strada, E.; Battistelli, L.; Savazzi, G. 2008: Bence-Jones proteinuria and kidney's damages Recenti Progressi in Medicina 99(7-8): 389-394
Juncà Piera, J.; Casals Pascual, A.; Formiguera Sala, X.; Millà Santos, F.; Flores López, A.; Rey-Joly Barroso, C. 1987: Bence Jones proteinuria 6 years in developing Medicina Clinica 88(9): 378-380
Wang, Z.S.; Wang, X.M.; Tao, L. 2017: A case report of IgA-κ light chain multiple myeloma following essential thrombocythaemia Zhonghua Nei Ke Za Zhi 56(9): 683-684